CartilaGen
Coralville
About CartilaGen
CartilaGen is a biotechnology startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $150.0K
- Last round: Grant (Nov 2022)
- Website: cartilagen.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/cartilagen-143475 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.